111 related articles for article (PubMed ID: 8819712)
1. [Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group].
Nishimura T; Hori M
Kaku Igaku; 1996 Jan; 33(1):27-32. PubMed ID: 8819712
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of co-enzyme Q10 on idiopathic dilated cardiomyopathy: assessment by iodine-123 labelled 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid myocardial single-photon emission tomography.
Kim Y; Sawada Y; Fujiwara G; Chiba H; Nishimura T
Eur J Nucl Med; 1997 Jun; 24(6):629-34. PubMed ID: 9169569
[TBL] [Abstract][Full Text] [Related]
3. beta-Methyl-p-(123I)-iodophenyl pentadecanoic acid single-photon emission computed tomography in cardiomyopathy.
Nishimura T
Int J Card Imaging; 1999 Feb; 15(1):41-8. PubMed ID: 10453402
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
[TBL] [Abstract][Full Text] [Related]
5. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cardiac events in patients with dilated cardiomyopathy using 123I-BMIPP and 201Tl myocardial scintigraphy.
Inoue A; Fujimoto S; Yamashina S; Yamazaki J
Ann Nucl Med; 2007 Sep; 21(7):399-404. PubMed ID: 17876553
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of 123I-BMIPP myocardial SPECT].
Yamazaki J
Kaku Igaku; 1998 Jul; 35(6):367-73. PubMed ID: 9753915
[TBL] [Abstract][Full Text] [Related]
9. Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3- R,S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy.
Yoshinaga K; Tahara M; Torii H; Kihara K
Ann Nucl Med; 1998 Dec; 12(6):341-7. PubMed ID: 9972371
[TBL] [Abstract][Full Text] [Related]
10. Myocardial defect detected by 123I-BMIPP scintigraphy and left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy.
Hashimoto Y; Yamabe H; Yokoyama M
Ann Nucl Med; 1996 May; 10(2):225-30. PubMed ID: 8800452
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of 123I-BMIPP scanning for distinction of ischemic from nonischemic dilated cardiomyopathy].
Hirose Y; Ishida Y; Hayashida K; Kawano S; Fukuoka S; Uehara T; Nishimura T
Kaku Igaku; 1996 Jan; 33(1):19-25. PubMed ID: 8819711
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of 123I-BMIPP imaging in patients with Takotsubo cardiomyopathy.
Matsuo S; Nakajima K; Kinuya S; Yamagishi M
J Cardiol; 2014 Jul; 64(1):49-56. PubMed ID: 24331764
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear medicine imaging for cardiomyopathy].
Nakajima K; Taki J; Tonami N
Nihon Rinsho; 2000 Jan; 58(1):48-52. PubMed ID: 10885287
[TBL] [Abstract][Full Text] [Related]
15. [Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency].
Watanabe K; Miyajima S; Kusano Y; Tanabe N; Hirokawa Y
Kaku Igaku; 1997 Jul; 34(7):481-6. PubMed ID: 9293711
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
[TBL] [Abstract][Full Text] [Related]
17. [Assessment of myocardial fatty acid metabolism in patients with vasospastic angina using 123I-BMIPP myocardial SPECT].
Ito K; Sugihara H; Terada K; Matsumoto K; Taniguchi Y; Ohtsuki K; Miyazaki H; Nakagawa T; Azuma A; Maeda T
Kaku Igaku; 1995 Oct; 32(10):1099-106. PubMed ID: 8523832
[TBL] [Abstract][Full Text] [Related]
18. [A case of dilated cardiomyopathy with early back-diffusion of 123I-BMIPP].
Yoshida S; Kobayashi H; Iguchi N; Inoue S; Maki M; Hosoda S; Kusakabe K
Kaku Igaku; 1996 Mar; 33(3):261-6. PubMed ID: 8622258
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of improvement of left ventricular wall motion in patients with myocardial infarction--by using 99mTc-tetrofosmin and 123I-BMIPP myocardial SPECT at subacute phase].
Akimoto N
Kaku Igaku; 2000 Jul; 37(4):291-301. PubMed ID: 10965649
[TBL] [Abstract][Full Text] [Related]
20. [The serial change of the 123I-BMIPP SPECT in patients with hypertrophic cardiomyopathy].
Okuyama C; Sugihara H; Ito K; Yoneyama S; Terada K; Taniguchi Y; Matsumoto K; Ushijima Y; Nakagawa M; Maeda T
Kaku Igaku; 1996 Dec; 33(12):1329-36. PubMed ID: 9023439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
